dalteparin and pentoxifylline

dalteparin has been researched along with pentoxifylline in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akdemir, I; Erol, FS; Gursu, F; Kaplan, M; Kilic, N; Tiftikci, M; Topsakal, C1
Aggermann, T; Binder, S; Haas, P1
Ertem, K1
Boztosun, A; Cetin, A; Gulturk, S; Kosar, MI; Piçnak, A1
Furka, I; Kiss, F; Klarik, Z; Kotan, R; Miko, I; Nemeth, N; Peto, K; Posan, J; Sapy, P; Szentkereszty, Z1
Acar, M; Dogan, B; Senel, S; Zorlu, P1
Damm, R; Gademann, G; Hass, P; Kropf, S; Mohnike, K; Pech, M; Ricke, J; Sangro, B; Seidensticker, M; Seidensticker, R; Wust, P1

Trials

1 trial(s) available for dalteparin and pentoxifylline

ArticleYear
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Enoxaparin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pentoxifylline; Prospective Studies; Radiation Injuries; Ursodeoxycholic Acid

2014

Other Studies

6 other study(ies) available for dalteparin and pentoxifylline

ArticleYear
Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
    Acta neurochirurgica, 2002, Volume: 144, Issue:10

    Topics: Animals; Antioxidants; Enoxaparin; Homocysteine; Lipid Peroxidation; Male; Medroxyprogesterone Acetate; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Spinal Cord Ischemia

2002
Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2007, Volume: 27, Issue:3

    Topics: Dalteparin; Fibrinolytic Agents; Fundus Oculi; Humans; Livedo Reticularis; Male; Middle Aged; Pentoxifylline; Platelet Aggregation Inhibitors; Retina; Retinal Diseases; Retinal Vein; Retinal Vein Occlusion; Sneddon Syndrome; Treatment Outcome; Vision, Low

2007
Prolonged transient hand ischaemia secondary to a penicillin skin test.
    The Journal of hand surgery, European volume, 2007, Volume: 32, Issue:6

    Topics: Aspirin; Calcium Channel Blockers; Cyanosis; Drug Hypersensitivity; Drug Therapy, Combination; Fibrinolytic Agents; Fingers; Follow-Up Studies; Hand; Humans; Intradermal Tests; Ischemia; Male; Middle Aged; Nadroparin; Nifedipine; Penicillins; Pentoxifylline; Vasodilator Agents

2007
Effects of methylene blue, pentoxyphylline and enoxaparin on postoperative adhesion formation and markers of angiogenesis in a rat uterine horn model.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:1

    Topics: Animals; Enoxaparin; Enzyme Inhibitors; Female; Fibrinolytic Agents; Free Radical Scavengers; Immunohistochemistry; Methylene Blue; Neovascularization, Pathologic; Pentoxifylline; Random Allocation; Rats; Rats, Wistar; Tissue Adhesions; Uterus

2012
Effects of various drugs (flunixin, pentoxifylline, enoxaparin) modulating micro-rheological changes in cerulein-induced acute pancreatitis in the rat.
    Clinical hemorheology and microcirculation, 2014, Volume: 57, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Ceruletide; Clonixin; Enoxaparin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Microcirculation; Pancreatitis; Pentoxifylline; Rats; Vasodilator Agents

2014
Successfully treated fingertip necrosis in an infant with primary Raynaud phenomenon.
    Indian journal of pediatrics, 2014, Volume: 81, Issue:12

    Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fingers; Humans; Infant; Male; Necrosis; Nifedipine; Pentoxifylline; Raynaud Disease; Vasodilator Agents

2014